glp-1 vs glp-1/gip Simplified summary of the biological actions of GIP and as Psychological and behavioral effects of

In contrast to conditions like hypertension or type 2 diabetes, where interdisciplinary modelscombining pharmacotherapy, patient education, and behavioral supporthave long been standard, obesity care has historically lacked a comparable structure

I think I love it even more now

The FDA and other global regulatory bodies have approved several GLP-1 agonists for managing type 2 diabetes, such as: Semaglutide (Ozempic, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) These approvals were granted after rigorous clinical trials demonstrated their efficacy and safety for glycemic control

Recalculate before drawing

Shortages of GLP-1 medications, like Ozempic and Wegovy, are common occurrences

Friedmann Angeli JP, Conrad M